Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study

Spanish observational study (n=217) noted most common off-label indications included unspecified dyspnoea (not related to COPD or asthma), respiratory infections and heart failure. Authors suggest further research on off-label indications is needed to clarify safety and efficacy.

European Journal of Hospital Pharmacy